CAMP news

Latest 3 stories ยท newest Sep 28, 2026

CAMP
Camp4 enters securities pact with Decibel II Acquisition

Camp4 Therapeutics Corp entered into a securities purchase agreement with Decibel II Acquisition Corp, regarding a potential business combination.

CAMP
Camp4 secures TGA clearance for CMP-002 trial.

Camp4 Therapeutics received Australian regulatory approval to begin a Phase 1/2 clinical trial of CMP-002 for SYNGAP1 disorder. This milestone enables a second private offering that could raise up to $50 million.

CAMP
W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same CAMP feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/CAMP/newsSTART FREE